Agreed NZ.
This is an excellent interview.
I wonder if the wider market will pick up on the significance of the magnitude of the "Elanco Option"?
IMO, Elanco, will be willing to pay just about anything to get MPL back on their books, after-all, PAA has stolen their leading product right from under their noses.
This puts PAA in a very enviable position in regards to Bio Techs.
Elanco will want to play and for that, they are going to have to pay!!
As Always
Best
Mickey Mouse
Roger Aston CEO Pharmaust , Moving Forward Faster, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 93524 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 71004 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable
